Epithelial-mesenchymal transition (EMT) is essential for
TGF-β has dual roles in cancer by acting as a tumour suppressor in early tumour development, and paradoxically, by promoting tumour cell invasion in later stages 4 . Cooperation of TGF-β and other signalling pathways, such as Ras, is required for complete EMT 2,4,5
. TGF-β binding to its receptors leads to phosphorylation of SMAD2/3, which partner with SMAD4 and translocate to the nucleus where SMAD transcriptional complexes control the expression of target genes 8 . SMADs have low affinity for DNA and interact with DNA-binding cofactors to achieve high affinity and selectivity for specific target genes. Therefore, cells read TGF-β signals differently and the outcome of the response depends on the array of SMAD cofactors active at the time of exposure 8 . SMAD signalling is essential for TGF-β-induced EMT 5 and SMAD4 promotes tumour cell invasion in advanced pancreatic tumours 9 . The transcription factor SNAIL1 has a key role in EMT both during development and in tumour progression 10 by repressing junction components such as E-cadherin 11, 12 , claudins, occludin 13 and desmoplakin 12 . SNAIL1 is activated by multiple pathways 6, 7 and negatively regulated by GSK-3β 14, 15 and it is specifically activated at the tumourstroma interface 16 . The documented involvement of SMADs and SNAIL1 in EMT prompted us to investigate whether these transcription factors could cooperate to regulate gene expression in TGF-β-induced EMT. In particular, we studied the regulation of the Coxsackie-and adenovirus receptor (CAR), a tight-junction-associated cell adhesion molecule, which is downregulated in human cancer and in TGF-β-induced EMT [17] [18] [19] , and E-cadherin, an established marker of EMT. CAR is predominantly expressed in epithelial cells where it contributes to tightjunction formation and barrier function 17, 20 . A role for CAR as a tumour suppressor has been suggested on the basis of studies showing that loss of CAR is associated with aggressive bladder cancer 21 ; overexpression of CAR reduces the metastatic potential of tumour cells 22 . CAR is regulated by the Raf-MEK-ERK pathway during carcinoma progression 23 but the transcriptional mechanisms have not been determined. Here, we used two established in vitro models of TGF-β-induced EMT to investigate the involvement of SNAIL1 and SMADs in the regulation of CAR and E-cadherin.
EpH4-EpRas-EpXT is a model of stable EMT in mouse breast epithelial cells, induced by the cooperative actions of TGF-β and Ras 24 . EpXT cells showed EMT characteristics, including repression of E-cadherin, upregulation of vimentin (Fig. 1a, e) and N-cadherin ( Supplementary Information, Fig. S1a) , and a mesenchymal morphology compared with EpH4 cells (Fig. 1e) . Expression of CAR, occludin and claudin-3 was reduced in EpXT cells, compared with EpH4 cells at the protein and mRNA levels ( Fig. 1a, b ; Supplementary Information, Fig. S1a ), indicating that transcriptional repression was involved. The remaining CAR protein was discontinuously distributed along cell-cell contacts in EpXT cells (Fig. 1e) , suggesting that tight junctions were disorganized during EMT, as indicated by other studies 13 . Consistent with decreased CAR levels, EpXT cells were less sensitive to adenovirus infection, compared with EpH4 cells ( Supplementary  Information, Fig. S1a ).
NMuMG cells are frequently used as a model of inducible and transient TGF-β-mediated EMT 25 . TGF-β treatment of NMuMG cells resulted in EMT, with downregulation of CAR, E-cadherin and occludin, increased expression of vimentin and cell elongation (Fig. 1c, d, f) , as shown previously 18 . Similarly to EpXT cells, CAR distribution shifted from a continuous to a discontinuous pattern at cell-cell contacts after TGF-β-treatment (Fig. 1f) .
To determine the involvement of SNAIL1 and SMAD3/4 in the repression of CAR and other junction proteins in TGF-β-mediated EMT, we analysed the expression and intracellular localization of these transcription factors. Expression of SNAIL1, SMAD3 and SMAD4 was increased in EpXT, compared with EpH4 cells, at the protein (Fig. 1a) and mRNA levels ( Supplementary Information,Fig. S1b ). TGF-β treatment of NMuMG cells resulted in increased expression of SNAIL1 but did not significantly alter the expression of SMAD3 and SMAD4 (Fig. 1c,  Supplementary Information, Fig. S1c ).
SNAIL1 and SMAD3/4 were diffusely localized in the cytosol and nucleus in EpH4 and untreated NMuMG cells but concentrated in the nuclei of EpXT and TGF-β-treated NMuMG cells (Fig. 1g, h ). Nuclear translocation of SNAIL1 and SMAD3/4 occurred rapidly after TGF-β exposure and followed similar kinetics (data not shown). Computer-based sequence analysis showed that the mouse CAR promoter contained putative SNAIL1 sites (E-boxes) and SMAD binding elements (SBEs) (Fig. 2a) . To test whether SNAIL1 and/or SMAD3/4 could interact with the CAR promoter, we performed chromatin immunoprecipitation (ChIP) analysis using primers for five different regions of the CAR promoter (regions I-V, Fig. 2a,) . In EpXT cells, SNAIL1 and SMAD4 specifically interacted with regions I and IV (Fig. 2b) . The E-box in region I (CACCTG) conforms to the consensus SNAIL1 binding site (CANNTG), whereas the E-box in region IV (CAGGTT, reverse strand) differed slightly from the consensus sequence. However, CAGGTT sequences have previously been reported to confer binding sites for SNAIL1 (ref. 26) . SNAIL1 and SMAD4 interacted with regions I and IV where E-boxes and SBEs were located in close proximity to each other (16-18 base pairs apart), suggesting that they could bind DNA in a cooperative fashion.
Next, we compared the interaction of SNAIL1 and SMAD3/4 with the CAR promoter under EMT and non-EMT conditions. SNAIL1 and SMAD3/4 interacted with regions I and IV in EpXT and TGF-β-treated NMuMG cells but were less detectable in EpH4 and untreated NMuMG cells (Fig. 2c, d ). SMAD3 interacted with region I of the CAR promoter in its phosphorylated form (Fig. 2c) .
Putative SBEs were also found adjacent to E-boxes in E-cadherin, occludin and claudin-3 promoters ( Supplementary Information,  Fig. S2f ), suggesting that cooperative binding of SNAIL1 and SMADs could be a general mechanism of action of these transcription factors. Additionally, a SMAD4-specific binding site was recently mapped to a location close to E-boxes in the E-cadherin promoter 27 . ChIP analysis showed that SNAIL1 and SMAD4, and to a lesser extent SMAD3, interacted with this particular region of the E-cadherin promoter in EpXT, but not in EpH4 cells (Fig. 2c) . Thus, during TGF-β-induced EMT, SNAIL1 and SMAD3/4 were translocated to the nucleus and targeted to regions within CAR and E-cadherin promoters containing adjacent E-boxes and SBEs, suggesting that they may interact and cooperatively regulate gene expression.
To determine whether SNAIL1 interacted with SMAD3/4, we performed co-immunoprecipitation studies. In whole-cell extracts from EpXT cells, we found SNAIL1 in complex with SMAD3 and SMAD4 (Fig. 2e) . In nuclear extracts, SMAD4 was found in complex with SNAIL1 ( Supplementary Information, Fig. S1d ). The interaction between SNAIL1 and SMAD3/4 was not restricted to EpXT cells but also found in NMuMG (Fig. 2f ) and EpH4 cells (data not shown). This suggests that although nuclear accumulation and recruitment of SNAIL1 and SMAD3/4 to CAR and E-cadherin promoters was specific to EMT, the interaction was not.
The capacity of SNAIL1 and SMAD3/4, separately or in combination, to regulate the activity of CAR, E-cadherin, occludin and claudin-3 promoters was analysed by reporter assays in EpH4 cells. SNAIL1 repressed CAR, E-cadherin and occludin promoter activities by 40-60% (Fig. 3a-c) , whereas SMAD3 or SMAD4 alone did not cause significant repression The combination of SNAIL1 and SMAD3/4 repressed CAR, E-cadherin and occludin promoters by 70-80%, which was significantly more efficient than either SNAIL1 or SMAD3/4 separately ( Fig. 3a-c) . The claudin-3 promoter was also significantly repressed (50%) by the combination of SNAIL1 and SMAD3/4 ( To study the importance of specific SNAIL1 and SMAD binding sites for the cooperative repression of SNAIL1 and SMAD3/4, we generated wild-type and mutant (single or double) reporter constructs of region I of the CAR promoter (Fig. 3e) . Wild-type and mutant promoters had comparable activities when transfected into EpH4 cells ( Fig. 3f ) and were similarly repressed by SNAIL1 and SMAD3/4. However, repression of the double mutant promoter was significantly less, compared with the wild-type promoter, indicating the importance of the adjacent Ebox and SBE sites for the cooperative effects of SNAIL1 and SMAD3/4 (Fig. 3f) . Stability and nuclear activity of SNAIL1 are negatively regulated by phosphorylation through GSK-3β 14, 15 , which is inhibited by multiple pathways including Ras/PI3K and Wnt signalling. We hypothesized that stabilization of SNAIL1 through inhibition of GSK-3β would result in more potent repression of junction proteins during TGF-β-induced EMT. To test this, we treated NMuMG cells with TGF-β in the presence or absence of a GSK-3β inhibitor. The GSK-3β inhibitor alone decreased CAR and E-cadherin mRNA levels by 20-30% (Fig. 3g) but did not affect the expression or localization of CAR, E-cadherin, SNAIL1 or SMAD3/4 proteins ( Fig. 3g, h; Supplementary Information, Fig. S3a, b) . However, the interact and form a transcriptional repressor complex, which is targeted to adjacent E-boxes (E) and SBE sites in genes encoding junction proteins such as CAR, occludin and E-cadherin. As a result, these genes are repressed.
combination of TGF-β and the GSK-3β inhibitor resulted in more potent repression of CAR and E-cadherin (Fig. 3g, h ) and increased expression of SNAIL1 and SMAD3/4 protein (Fig. 3h) . RNA levels were less affected ( Supplementary Information, Fig. S3a) , indicating that the increases in SNAIL1 and SMAD3/4 were caused by enhanced protein stability, and that an increased pool of SNAIL1 and SMAD3/4 transcription factors were available to form a complex resulting in more efficient repression of junction proteins during EMT.
To further examine the involvement of SNAIL1 and SMAD3/4 in the repression of CAR and other junction proteins during TGF-β-induced EMT, we used short interfering RNAs (siRNAs) to silence these transcription factors in NMuMG cells. Using SNAIL1 and SMAD4 siRNAs, SNAIL1 was repressed by 50% and SMAD4 by 70%, respectively, both under baseline conditions and after TGF-β (Fig. 4a, b) . Silencing of SNAIL1 significantly rescued the repression of CAR and occludin (Fig. 4c, d ) after TGF-β. E-cadherin was marginally rescued by SNAIL1 siRNA (Fig. 4e) , suggesting that repression of CAR and occludin was more dependent on SNAIL1. SMAD4 silencing resulted in significant rescue of CAR, occludin and E-cadherin (Fig. 4c-e) repression after TGF-β. As our previous results showed that SNAIL1 and SMAD3/4 functioned as co-repressors, we examined whether the combination of SNAIL1 and SMAD4 siRNAs was more potent in rescuing TGF-β-induced repression. Indeed, co-silencing of SNAIL1 and SMAD4 resulted in complete rescue of CAR and occludin repression after TGF-β (Fig. 4c, d) . For E-cadherin, no additive rescue effect of using both SNAIL1 and SMAD4 siRNAs was observed (Fig. 4e) . The involvement of SMAD3 was determined by using a specific inhibitor of SMAD3 (SIS3), which caused significant rescue of both CAR and E-cadherin repression after TGF-β (Fig. 4f) .
Together, these results demonstrate that SNAIL1 is a cofactor for SMAD3/4 and that SNAIL1-SMAD3/4 complexes during TGF-β-induced EMT are recruited to CAR, occludin and E-cadherin promoters, where E-boxes and SBEs are located in close proximity to each other (Fig. 4g) . As a result, the transcription of these genes is repressed.
Repression of E-cadherin in NMuMG cells was less dependent on SNAIL1, compared with CAR and occludin, which is consistent with published data and indicates that other transcriptional repressors, such as SIP1 and δEF1, repress E-cadherin in NMuMG cells during TGF-β-induced EMT 28 . However, as SNAIL1 was incompletely blocked, one cannot exclude the possibility that SNAIL1 contributes to the repression of E-cadherin in NMuMG cells.
The importance of the SNAIL1-SMAD3/4 complex for EMT in cultured breast epithelial cells encouraged us to demonstrate in vivo evidence of SNAIL1 and SMAD3/4 cooperation in invasive breast cancer. First, we used a mouse model of subcutaneously grown D2F2 breast carcinoma cells overexpressing human HER-2 (D2F2/E2), which results in the establishment of tumours with invasive properties and the capacity to metastasize to the lungs 29 . Established tumours were composed of morphologically distinct compartments containing cells with either an epithelial or mesenchymal morphology (Fig. 5a ). Cells in both compartments were positive for HER-2, indicating that the mesenchymal-like cells had originated from the initial pool of injected tumour cells that had undergone EMTlike changes during tumour formation in vivo. In agreement with this, mesenchymal cells were positive for vimentin, whereas the epithelial cells expressed CAR and E-cadherin (Fig. 5a ). SNAIL1 and SMAD4 were not detected in cells in the epithelial compartment but were co-expressed in the nuclei of cells in the mesenchymal compartment (Fig. 5b) . This supports a role for the SNAIL1-SMAD3/4 complex in the induction of EMT in this subcutaneous mouse model of breast carcinoma.
Second, we analysed a series of 25 human infiltrating ductal breast carcinomas for co-expression of SNAIL1 and SMAD3/4 and loss of CAR or E-cadherin expression. Significant expression of SNAIL1 was found in 8 cases where it was confined to the nuclei of tumour cells at the invasive front. The expression of SMAD3 and SMAD4 was more ubiquitous (Fig. 5c, d ). CAR and E-cadherin were detected at junctions between tumour cells except in areas of invasion, where the expression was reduced or lost. Loss of CAR and E-cadherin correlated with nuclear co-expression of SNAIL1 and SMAD3/4 ( Fig. 5c, d ; Supplementary  Information, Fig. S4a-c) . SMAD3/4-expressing tumour cells positive for SNAIL1 expressed significantly less CAR and E-cadherin, compared with cells negative for SNAIL1 (Fig. 5e) . These results support the cooperative roles of SNAIL1-SMAD3/4 in the induction of EMT during tumour cell invasion.
In summary, we found that SNAIL1 is a cofactor for SMAD3/4 and that these transcription factors form a transcriptional repressor complex, which, during TGF-β-induced EMT, represses CAR, occludin and E-cadherin transcription. Thus, cooperation of SNAIL1 and SMAD3/4 transcription factors affects the outcome of the TGF-β response in cells. A strong correlation was found between loss of CAR and E-cadherin and nuclear co-expression of SNAIL1 and SMAD3/4 at the invasive front of breast carcinomas in support of a role for SNAIL1-SMAD3/4 complexes in human cancer.
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METHODS
Cell Culture. EpH4 and EpXT cells (provided by H. Beug, Institute of Molecular Pathology, Vienna Medical University,Vienna, Austria) were cultivated as described previously 2 . In this model, EMT was induced in two steps: first, mouse mammary epithelial EpH4 cells were transformed with oncogenic Ha-Ras (EpRas) and implanted subcutaneously in BALB/c mice where they rapidly formed tumours and acquired a mesenchymal morphology. Second, xenografted cells (EpXT) of the tumours were cultured and shown to have features of EMT and to produce TGF-β, which acts in an autocrine loop to maintain the mesenchymal phenotype. Namru murine mammary gland (NMuMG) cells were cultured as described previously 25 . Transient EMT was induced in NMuMG cells by the addition of TGF-β (10 ng ml -1 ; R&D Systems) for 12-72 h. NMuMG cells were incubated with the GSK-3β inhibitor (5 μM; Calbiochem/VWR International AB) alone or in combination with TGF-β (10 ng ml TGF-β1 (R&D Systems) was diluted in 4 mM HCl (2 μg ml -1
) and the GSK-3β inhibitor, BIO-(2´Z, 3´E)-6-bromoindirubin-3´-oxime 32 (Calbiochem) was diluted to 10 mM in DMSO. Aliquots of both were stored at -20 °C. The specific inhibitor of Smad3 (SIS3, Calbiochem) was used at a concentration of 10 μM, as reported previously 33 .
Plasmid and adenovirus vectors. The plasmid encoding human wild-type SNAIL1 was provided by M. C. Hung (Department of Molecular and Cellular Oncology, The University of Texas, USA) 15 . Plasmids encoding SMAD3 and SMAD4 have been described previously 34 . The reporter construct plasmids encoding the upstream region of mouse and human E-cadherin promoters (Ecad3/Luc) was provided by E. R. Fearon (Programme in Cellular and Molecular Biology, University of Michigan Medical School, Michigan, USA) 35 . A 2-kb upstream region of the CAR gene was subcloned from a BAC clone harbouring the entire mouse CAR gene, which was provided by B. Andersson (Center for Genomics & Bioinformatics, Karolinska Institute, Stockholm, Sweden) using the restriction sites Eag I and XhoI and subcloned into a pGL-3 basic vector (Promega). Plasmids encoding human occludin and mouse claudin-3 promoters were provided by J. Mankertz (Department of Gastroenterology, Infectiology and Rheumatology, Charité -Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany) and M. Furuse (Division of Cellular and Molecular Medicine, Kobe University, Japan), respectively. A plasmid encoding the β-galactosidase gene (βgal) under the CMV promoter was used as an internal control of transfection efficiency in all reporter assays.
For mutational analysis, the putative E-box and SBE sites in region I of the mouse CAR promoter were mutated using the QuikChange site-directed mutagenesis kit (Stratagene) with primers shown in Supplementary Information, Table S1 . Wild-type and mutated CAR region I sequences were cloned between BglII and HindIII sites of a mutated version 11 of the pGL-3 Luciferase vector (Promega). All constructs were confirmed by sequencing.
The adenovirus vector expressing green fluorescent protein (Ad-GFP) is an E1 -E3 -replication-deficient recombinant Ad gene transfer vector with a GFP expression cassette inserted into the E1 position of the viral genome, as described elsewhere 36 .
Adenovirus infection. Cells were grown to 70% confluence and infected with Ad-GFP using a multiplicity of infection of 100 at 37 °C for 1 h and analysed 24 h later by fluorescence microscopy. At least five independent fields were chosen.
Immunofluorescence microscopy. Cells were grown on coverslips and, depending on the antibody used for staining, were either fixed in absolute ethanol (junction proteins CAR, E-cadherin, N-cadherin) or in 4% paraformaldehyde (transcription factors SNAIL1, SMAD3 and SMAD4), permeabilized and stained with primary antibodies followed by secondary Alexa 488 or Alexa 594-conjugated mouse or rabbit antibodies. Slides were examined and photographed using a Zeiss Axiophot fluorescence microscope. Nuclei were counterstained with DAPI.
Immunoprecipitation and western blotting. Cells were lysed in RIPA buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS supplemented with protease inhibitors (Complete, Roche,) and total protein extracts were boiled in Laemmli sample buffer (BioRad), separated by SDS-PAGE under reducing conditions and transferred to nitrocellulose. Immunoreactive bands were visualized by chemiluminescence (Supersignal, Pierce/Thermo Scientific/Nordic Biolabs) and developed using a LAS1000 system (Fuji Photo Film Co.).
EpXT and TGF-β-treated (12 h) or untreated NMuMG cells were grown to 70%-80% confluence, treated for 3 h with MG-132 (20 μM; Sigma Aldrich) and lysed by brief sonication (3 × 1 s pulses) in co-immunoprecipitation buffer (10 mM Hepes pH 8.0, 300 mM NaCl, 0.1 mM EDTA, 20% glycerol, 0.2% NP-40 supplemented with protease (Complete, Roche) and phosphatase (Calbiochem) inhibitors and 1 μM MG-132). Lysates were centrifuged for 20 min at 10,000g and the resulting supernatant was precleared by incubation with immobilized ProteinA/G gel (25 μl; Pierce) for 1.5 h at 4 °C. The precleared supernatant was subjected to overnight immunoprecipitation using rabbit polyclonal SMAD3 (Cell Signaling), polyclonal SMAD-4 (Upstate Biotechnologies/Millipore) or polyclonal control IgG antibodies at 4 °C. The next day protein complexes were collected by incubation with 25 μl immobilized Protein A/G gel for 1.5 h at 4 °C. The collected protein complexes were washed four times with co-immunoprecipitation buffer and eluted by boiling in Laemmli sample buffer under reducing conditions after which proteins were resolved on SDS-PAGE and analysed by western blot. For nuclear extracts, EpXT cells were treated with 0.5 mM of the membrane-permeable, cleavable crosslinker dithiobis-succinimidylpropionate (DSP, Sigma-Aldrich) for 20 min at room temperature. Immunoprecipitations following standard procedures were performed using nuclear extracts (200 μg of total protein) for 1 h at 4 °C with monoclonal antibodies against SNAIL1. The immunoprecipitated complexes were boiled in Laemmli sample buffer (Bio-Rad) under reducing conditions for 20 min, and proteins were resolved on SDS-PAGE and analysed by western blotting.
Semi-quantitative real-time PCR. Total RNA was isolated from EpH4 and EpXT cells and purified using RNeasy Mini Kit (Qiagen), supplemented with RNase-Free DNase (Qiagen). cDNA was obtained using the iScript Select cDNA Synthesis Kit (Bio-Rad Laboratories AB) and the absence of DNA contamination was verified by excluding reverse transcriptase. cDNA aliquots were subjected to PCR reactions using the QuantiTect SYBR Green PCR Kit (Qiagen) to amplify CAR, occludin, claudin-3, E-cadherin, SMAD3, SMAD4, SNAIL1 and GAPDH with primers ( Supplementary Information, Table S1 ) using QuantiTect primer assays (Qiagen). Each PCR reaction was carried out as follows: 15 min at 95 °C, 15 s at 94 °C, 30 s at 55 °C, and 30 s at 72 °C. Each cycle was repeated 40 times, according to the manufacturer's recommendations, using the Rotorgene RG-3000A thermal cycler, and Rotorgene 6.0 software (Corbett Research). On the basis of the comparative Ct method, gene expression levels were calculated and GAPDH was used as a control gene. EpH4 or untreated NMuMG samples were set to 100% and fold change in expression in XT and TGF-β treated NMuMG are represented as bar graphs (mean ± s.e.m.).
Luciferase reporter assays. EpH4 cells were transfected with CAR, E-cadherin, occludin and claudin-3 promoter constructs, separately or in combination with plasmids expressing SNAIL1, SMAD3 or SMAD4 transcription factors using Lipofectamine 2000 transfection reagent (Invitrogen) according to standard procedures. A plasmid encoding β-galactosidase (β-gal) was co-transfected as a control for transfection efficiency and used for normalizing the data. Luciferase and 
